<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Conavi Medical Corp. — News on 6ix</title>
    <link>https://6ix.com/company/conavi-medical-corp</link>
    <description>Latest news and press releases for Conavi Medical Corp. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 23 Apr 2026 11:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/conavi-medical-corp" rel="self" type="application/rss+xml" />
    <item>
      <title>Conavi Medical Awarded 2026 TAG Innovation Award</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-awarded-2026-tag-innovation-award</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-awarded-2026-tag-innovation-award</guid>
      <pubDate>Thu, 23 Apr 2026 11:00:00 GMT</pubDate>
      <description>TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (&amp;#x201C;Conavi&amp;#x201D; or the &amp;...</description>
    </item>
    <item>
      <title>Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-announces-fda-510k-clearance-of-its-next-generation-hybrid-ivus-oct-system-for-intravascular-imaging</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-announces-fda-510k-clearance-of-its-next-generation-hybrid-ivus-oct-system-for-intravascular-imaging</guid>
      <pubDate>Mon, 20 Apr 2026 11:00:00 GMT</pubDate>
      <description>- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging&amp;#xA0;   - Compan...</description>
    </item>
    <item>
      <title>Conavi Medical to Present at the 2026 Bloom Burton &amp; Co. Healthcare Investor Conference</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-to-present-at-the-2026-bloom-burton-and-co-healthcare-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-to-present-at-the-2026-bloom-burton-and-co-healthcare-investor-conference</guid>
      <pubDate>Thu, 09 Apr 2026 11:00:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CN...</description>
    </item>
    <item>
      <title>Conavi Medical Announces Results from Its Annual General Meeting of Shareholders</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-announces-results-from-its-annual-general-meeting-of-shareholders</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-announces-results-from-its-annual-general-meeting-of-shareholders</guid>
      <pubDate>Thu, 02 Apr 2026 21:44:30 GMT</pubDate>
      <description>TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp.  (TSXV: CNVI; OTCQB: CNVIF)  (&amp;#...</description>
    </item>
    <item>
      <title>Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-reports-fiscal-first-quarter-2026-results-and-operational-highlights</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-reports-fiscal-first-quarter-2026-results-and-operational-highlights</guid>
      <pubDate>Thu, 26 Feb 2026 12:05:00 GMT</pubDate>
      <description>- Successfully Closes $12M Public Offering, Strengthens Balance Sheet and Supports Anticipated U.S. Launch- Recent Peer-Reviewed Publication Demonstrates Advantages of Hybrid IVUS-OCT Imaging TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results an</description>
    </item>
    <item>
      <title>Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-highlights-peer-reviewed-120000563</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-highlights-peer-reviewed-120000563</guid>
      <pubDate>Fri, 13 Feb 2026 12:00:00 GMT</pubDate>
      <description>- New Academic Data Supports Clinical and Commercial Value of Hybrid Imaging Platform-TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new peer-reviewed research titled “Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology,” publish</description>
    </item>
    <item>
      <title>Conavi Medical Corp. Announces Closing of $12M Public Offering</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-closing-140500168</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-closing-140500168</guid>
      <pubDate>Tue, 13 Jan 2026 14:05:00 GMT</pubDate>
      <description>NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce that it has closed its previously announced equity offering for aggregate gross proceeds of approximately</description>
    </item>
    <item>
      <title>Conavi Medical Corp. Announces Filing of Amended &amp; Restated Final Prospectus&amp;#xA0;&amp;#xA0;</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-filing-of-amended-and-restated-final-prospectusandxa0andxa0</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-filing-of-amended-and-restated-final-prospectusandxa0andxa0</guid>
      <pubDate>Thu, 08 Jan 2026 02:38:18 GMT</pubDate>
      <description>NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES      A&amp;...</description>
    </item>
    <item>
      <title>Conavi Medical Corp. Announces Filing of Amended &amp; Restated Final Prospectus</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-filing-023800612</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-filing-023800612</guid>
      <pubDate>Thu, 08 Jan 2026 02:38:00 GMT</pubDate>
      <description>NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&amp;R FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to provide an update in respect of its previously announced public</description>
    </item>
    <item>
      <title>Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-reports-fiscal-year-2025-results-and-operational-highlights</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-reports-fiscal-year-2025-results-and-operational-highlights</guid>
      <pubDate>Mon, 29 Dec 2025 12:38:29 GMT</pubDate>
      <description>Next-Generation Novasight Hybrid&amp;#x2122; System Submitted to U.S. FDA for 510(k) Clearance   U.S....</description>
    </item>
    <item>
      <title>Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-pricing-of-public-offering-of-common-shares-andor-pre-funded-warrants</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-pricing-of-public-offering-of-common-shares-andor-pre-funded-warrants</guid>
      <pubDate>Thu, 18 Dec 2025 13:45:00 GMT</pubDate>
      <description>NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES      FI...</description>
    </item>
    <item>
      <title>Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-proposed-public-offering-of-common-shares-and-pre-funded-warrants</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-corp-announces-proposed-public-offering-of-common-shares-and-pre-funded-warrants</guid>
      <pubDate>Fri, 21 Nov 2025 21:30:51 GMT</pubDate>
      <description>PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+           NOT FOR RELEASE OR DISTRIBUTION IN THE UNIT...</description>
    </item>
    <item>
      <title>Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-expands-leadership-team-to-support-next-phase-of-us-commercialization</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-expands-leadership-team-to-support-next-phase-of-us-commercialization</guid>
      <pubDate>Mon, 03 Nov 2025 12:00:00 GMT</pubDate>
      <description>- Mark Quick Appointed Chief Financial Officer, Bringing Extensive Public Company Capital Markets...</description>
    </item>
    <item>
      <title>Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-announces-agreement-with-the-province-of-ontario-as-part-of-the-life-sciences-scale-up-fund</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-announces-agreement-with-the-province-of-ontario-as-part-of-the-life-sciences-scale-up-fund</guid>
      <pubDate>Wed, 29 Oct 2025 11:00:00 GMT</pubDate>
      <description>TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (&amp;#x2...</description>
    </item>
    <item>
      <title>Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-highlight-novasight-hybrid-110000671</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-highlight-novasight-hybrid-110000671</guid>
      <pubDate>Thu, 23 Oct 2025 11:00:00 GMT</pubDate>
      <description>Company to Participate in Educational Imaging Sessions and Feature Hybrid IVUS/OCT Imaging TechnologyTORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a commercial-stage medical device company focused on intravascular imaging solutions, today announced that it will participate in the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, taking place October 25 – 28, 2025, at the Moscone Center in San Francisco, California. Attendees w</description>
    </item>
    <item>
      <title>Conavi Medical to Highlight Novasight Hybrid(TM) Imaging at TCT 2025</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-to-highlight-novasight-hybridtm-imaging-at-tct-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-to-highlight-novasight-hybridtm-imaging-at-tct-2025</guid>
      <pubDate>Thu, 23 Oct 2025 11:00:00 GMT</pubDate>
      <description>TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a com...</description>
    </item>
    <item>
      <title>Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-to-present-at-the-planet-microcap-showcase-toronto-in-partnership-with-microcapclub-on-wednesday-october-22-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-to-present-at-the-planet-microcap-showcase-toronto-in-partnership-with-microcapclub-on-wednesday-october-22-2025</guid>
      <pubDate>Thu, 16 Oct 2025 11:00:00 GMT</pubDate>
      <description>TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (&amp;#x2...</description>
    </item>
    <item>
      <title>Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-submits-next-generation-novasight-hybrid-intravascular-imaging-system-to-us-fda-for-510k-clearance</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-submits-next-generation-novasight-hybrid-intravascular-imaging-system-to-us-fda-for-510k-clearance</guid>
      <pubDate>Tue, 16 Sep 2025 11:00:00 GMT</pubDate>
      <description>US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs             FDA 510(...</description>
    </item>
    <item>
      <title>Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/conavi-medical-reports-fiscal-q3-2025-interim-results-and-operational-highlights</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/conavi-medical-reports-fiscal-q3-2025-interim-results-and-operational-highlights</guid>
      <pubDate>Fri, 29 Aug 2025 11:00:00 GMT</pubDate>
      <description>US FDA 510(k) submission remains on track for calendar Q3 2025         Successful validation test...</description>
    </item>
    <item>
      <title>Novasight(TM) Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case</title>
      <link>https://6ix.com/company/conavi-medical-corp/news/novasighttm-hybrid-imaging-system-featured-in-published-jscai-case-report-demonstrating-superior-diagnosis-and-precision-guided-therapy-in-complex-coronary-case</link>
      <guid isPermaLink="true">https://6ix.com/company/conavi-medical-corp/news/novasighttm-hybrid-imaging-system-featured-in-published-jscai-case-report-demonstrating-superior-diagnosis-and-precision-guided-therapy-in-complex-coronary-case</guid>
      <pubDate>Wed, 30 Jul 2025 11:00:00 GMT</pubDate>
      <description>TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a lea...</description>
    </item>
  </channel>
</rss>